A panel of experts at #ABIMidAtlantic will focus on the #SCOTUS decision in Purdue Pharma and its impacts on chapter 11 going forward. Join the discussion at this and other key panels! Are you registered? https://ow.ly/9iLS50SLmOE
American Bankruptcy Institute’s Post
More Relevant Posts
-
A panel of experts at #ABIMidAtlantic will focus on the #SCOTUS decision in Purdue Pharma and its impacts on chapter 11 going forward. Join the discussion at this and other key panels! Are you registered? https://lnkd.in/eUghj_cj
To view or add a comment, sign in
-
-
A panel of experts at #ABIMidAtlantic will focus on the #SCOTUS decision in Purdue Pharma and its impacts on chapter 11 going forward. Join the discussion at this and other key panels! Are you registered? https://lnkd.in/eUghj_cj
To view or add a comment, sign in
-
-
A panel of experts at #ABIMidAtlantic will focus on the #SCOTUS decision in Purdue Pharma and its impacts on chapter 11 going forward. Join the discussion at this and other key panels! Are you registered? https://lnkd.in/eRRBHGJp
To view or add a comment, sign in
-
-
Part 3 is Here! Join Darwin Shurig and Aaron Snyder, VP of Quality at Allotex as they wrap up with a powerful discussion on #careergrowth, the critical role of #careerladders, and how they drive higher #retention, stability, and reduced risk in organizations. If you missed parts 1 and 2 make sure to check those out in the links below: https://lnkd.in/eqi7xSkh #medicaldevice #pharma #quality
To view or add a comment, sign in
-
This webinar is very worthwhile. Very interesting insights from Prof. Ding on the discovery and development of rFC. And, great commentary from Katie Carroll on the practicalities of deploying rFC in a sterile pharma manufacturing context.
The webinar held a few days ago with Pr. Ding, inventor of the #rFC method, and Katie Carroll from QuVa Pharma, Inc., was very insightful and taught us a lot about rFC, from scientific breakthrough to implementation. If you missed the original webinar, you can watch it on-demand anytime ➡ https://lnkd.in/ejad3i2y Feel free to connect with us to discuss your #Endotoxin detection method and how rFC can help you achieve reliable, and more sustainable, results.
To view or add a comment, sign in
-
-
We know that delays, bottlenecks, and rising costs can really slow down the drug development process. These are major challenges that biotech and pharma companies face, but there are ways to tackle them head-on. Leading CROs navigate these obstacles with innovative strategies to keep programs moving forward. My colleague, Vimal Patel, recently recorded a great on-demand webinar walking you through the cutting-edge bioanalytical strategies – including automation solutions – that help clients make smarter, faster decisions and accelerate their development timelines. Click this link to watch: https://okt.to/9KtFzE
To view or add a comment, sign in
-
-
We know that delays, bottlenecks, and rising costs can really slow down the drug development process. These are major challenges that biotech and pharma companies face, but there are ways to tackle them head-on. Leading CROs navigate these obstacles with innovative strategies to keep programs moving forward. My colleague, Vimal Patel, recently recorded a great on-demand webinar walking you through the cutting-edge bioanalytical strategies – including automation solutions – that help clients make smarter, faster decisions and accelerate their development timelines. Click this link to watch: https://okt.to/pzfWy0
To view or add a comment, sign in
-
-
Medtech faces hurdles ranging from biopharma capital limits to regulation. Read the latest from RSM senior analyst Amanda Laskey: https://rsm.buzz/425qvL1
To view or add a comment, sign in
-
-
💡 Join Catalyst Clinical Research for an informative webinar on how functional service providers (#FSPs) are transforming the clinical research landscape with specialized skills, adaptable resources, and cost-efficient solutions. With the increasing complexity of trials, many biotech and biopharma companies prefer FSPs over full-service outsourcing. FSPs offer numerous advantages, such as global strategies, expert domain knowledge, and efficient management, balancing quality, innovation, and cost. Learn about the strategic advantages, including expert domain knowledge, global strategies, and operational flexibility, that FSPs offer for biotech and biopharma companies in drug development. ➡️ Register here: https://buff.ly/3VTDT1e 🌟 Featured speakers: Svetlana Kolchinsky Melissa Church Craig McIlloney #ClinicalTrials #DrugDevelopment #DrugPricing #ClinicalResearch #DrugSafety #DrugManufacturing #FunctionalServiceProvider #Commercialization #HEOR #MarketAccess
To view or add a comment, sign in
-
-
We know that delays, bottlenecks, and rising costs can really slow down the drug development process. These are major challenges that biotech and pharma companies face, but there are ways to tackle them head-on. Leading CROs navigate these obstacles with innovative strategies to keep programs moving forward. My colleague, Vimal Patel, recently recorded a great on-demand webinar walking you through the cutting-edge bioanalytical strategies – including automation solutions – that help clients make smarter, faster decisions and accelerate their development timelines. Click this link to watch: https://okt.to/vbr3Kk
To view or add a comment, sign in
-